# Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects

> **NCT02485769** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 71 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06650833
- **DRUG:** Placebo
- **DRUG:** PF-06650833
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02485769
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2018-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485769, "Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02485769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*